These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 3902484

  • 1. Insulin binding on erythrocytes in unsatisfactorily controlled obese diabetics (type 2) and nonobese diabetics (type 1).
    Páv J, Hilgertová J, Srámková J.
    Exp Clin Endocrinol; 1985 Aug; 86(1):53-60. PubMed ID: 3902484
    [Abstract] [Full Text] [Related]

  • 2. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Rizkalla SW, Elgrably F, Tchobroutsky G, Slama G.
    Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
    [Abstract] [Full Text] [Related]

  • 3. Abnormal dietary regulation of erythrocyte insulin receptor affinity in non-insulin-dependent diabetes mellitus.
    Ward GM, Naylor BA, Sargent RM, Turner RC.
    Clin Endocrinol (Oxf); 1984 Jun; 20(6):671-81. PubMed ID: 6380826
    [Abstract] [Full Text] [Related]

  • 4. Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect.
    Bieger WP, Dlugosch R, Rettenmeier A, Holler HD, Bert H, Schwarz W, Fiehn W, Merkt J, Weicker H.
    Klin Wochenschr; 1984 Jul 02; 62(13):631-9. PubMed ID: 6434794
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Erythrocytes: a new cell type for the evaluation of insulin receptor defects in diabetic humans.
    Robinson TJ, Archer JA, Gambhir KK, Hollis VW, Carter L, Bradley C.
    Science; 1979 Jul 13; 205(4402):200-2. PubMed ID: 451590
    [Abstract] [Full Text] [Related]

  • 7. Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients.
    Trischitta V, Brunetti A, Chiavetta A, Benzi L, Papa V, Vigneri R.
    Diabetes; 1989 Dec 13; 38(12):1579-84. PubMed ID: 2684714
    [Abstract] [Full Text] [Related]

  • 8. Erythrocyte insulin receptors in non-insulin-dependent diabetics before and after treatment.
    Tanggo Y.
    Hiroshima J Med Sci; 1985 Sep 13; 34(3):331-45. PubMed ID: 3905718
    [No Abstract] [Full Text] [Related]

  • 9. Insulin binding to erythrocytes in diabetes mellitus.
    Okada Y, Arima T, Okazaki S, Nakata K, Yamabuki T, Nagashima H.
    Acta Med Okayama; 1981 Oct 13; 35(4):273-7. PubMed ID: 6457514
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Optimizing glycemic control with insulin glargine.
    Williams JB.
    Diabetes Technol Ther; 2003 Oct 13; 5(3):471-3. PubMed ID: 12828834
    [No Abstract] [Full Text] [Related]

  • 14. [Receptor binding of insulin to erythrocytes in healthy women and in patients with diabetes mellitus during pregnancy].
    Tikhonova NE, Kosheleva NG.
    Probl Endokrinol (Mosk); 1987 Oct 13; 33(5):18-23. PubMed ID: 3321032
    [Abstract] [Full Text] [Related]

  • 15. Relationship of insulin binding and insulin-stimulated tyrosine kinase activity is altered in type II diabetes.
    Comi RJ, Grunberger G, Gorden P.
    J Clin Invest; 1987 Feb 13; 79(2):453-62. PubMed ID: 3543053
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Is type 2 diabetes a different disease in obese and nonobese patients?
    Prando R, Cheli V, Melga P, Giusti R, Ciuchi E, Odetti P.
    Diabetes Care; 1998 Oct 13; 21(10):1680-5. PubMed ID: 9773730
    [Abstract] [Full Text] [Related]

  • 18. Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics.
    Laakso M, Voutilainen E, Sarlund H, Aro A, Pyörälä K, Penttilä I.
    Atherosclerosis; 1985 Sep 13; 56(3):271-81. PubMed ID: 3902037
    [Abstract] [Full Text] [Related]

  • 19. [Pyruvate kinase activity as a marker of erythrocyte age increases the reliability of the method of determining insulin binding to membrane receptors].
    Klimes I, Zórad S, Svábová E, Ficková M, Sorocinová E, Macho L.
    Vnitr Lek; 1987 Jun 13; 33(6):454-63. PubMed ID: 3310385
    [No Abstract] [Full Text] [Related]

  • 20. First experiments in taurine administration for diabetes mellitus. The effect on erythrocyte membranes.
    Elizarova EP, Nedosugova LV.
    Adv Exp Med Biol; 1996 Jun 13; 403():583-8. PubMed ID: 8915397
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.